1. Home
  2. NBIX vs THC Comparison

NBIX vs THC Comparison

Compare NBIX & THC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • THC
  • Stock Information
  • Founded
  • NBIX 1992
  • THC 1967
  • Country
  • NBIX United States
  • THC United States
  • Employees
  • NBIX N/A
  • THC N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • THC Hospital/Nursing Management
  • Sector
  • NBIX Health Care
  • THC Health Care
  • Exchange
  • NBIX Nasdaq
  • THC Nasdaq
  • Market Cap
  • NBIX 11.6B
  • THC 13.2B
  • IPO Year
  • NBIX 1996
  • THC N/A
  • Fundamental
  • Price
  • NBIX $120.69
  • THC $129.70
  • Analyst Decision
  • NBIX Buy
  • THC Buy
  • Analyst Count
  • NBIX 21
  • THC 18
  • Target Price
  • NBIX $168.35
  • THC $163.94
  • AVG Volume (30 Days)
  • NBIX 1.6M
  • THC 1.6M
  • Earning Date
  • NBIX 02-06-2025
  • THC 02-12-2025
  • Dividend Yield
  • NBIX N/A
  • THC N/A
  • EPS Growth
  • NBIX 33.20
  • THC 473.07
  • EPS
  • NBIX 3.29
  • THC 32.70
  • Revenue
  • NBIX $2,355,300,000.00
  • THC $20,665,000,000.00
  • Revenue This Year
  • NBIX $16.29
  • THC $3.99
  • Revenue Next Year
  • NBIX $16.90
  • THC $4.87
  • P/E Ratio
  • NBIX $36.68
  • THC $3.96
  • Revenue Growth
  • NBIX 24.81
  • THC 0.57
  • 52 Week Low
  • NBIX $110.95
  • THC $88.98
  • 52 Week High
  • NBIX $157.98
  • THC $171.20
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 35.76
  • THC 41.92
  • Support Level
  • NBIX $113.00
  • THC $131.74
  • Resistance Level
  • NBIX $118.61
  • THC $138.11
  • Average True Range (ATR)
  • NBIX 4.28
  • THC 6.67
  • MACD
  • NBIX -2.22
  • THC -0.88
  • Stochastic Oscillator
  • NBIX 18.81
  • THC 24.13

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

About THC Tenet Healthcare Corporation

Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Share on Social Networks: